Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2012-09-06 15:16:50 UTC |
---|
Update Date | 2022-03-07 02:51:47 UTC |
---|
HMDB ID | HMDB0014930 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Tripelennamine |
---|
Description | Tripelennamine, also known as PBZ-SR or azaron, belongs to the class of organic compounds known as 2-benzylaminopyridines. These are aromatic compounds containing pyridine ring substituted at the 2-position by a benzylamine group. In addition to its antihistamine properties, tripelennamine also acts as a weak serotonin-norepinephrine-dopamine reuptake inhibitor (SNDRI). Tripelennamine acts primarily as an antihistamine, or H1 receptor antagonist. Tripelennamine is a drug which is used for the symptomatic relief of hypersensitivity reactions, coughs, and the common cold. It can be used in the treatment of asthma, hay fever, rhinitis and urticaria, but is now less common as it has been replaced by newer antihistamines. Because of its SRI properties, tripelennamine was used as the basis for the development of the selective serotonin reuptake inhibitor (SSRI) fluoxetine (Prozac). Tripelennamine is a very strong basic compound (based on its pKa). In humans, tripelennamine is involved in tripelennamine h1-antihistamine action. Tripelennamine is mildly sedating. Tripelennamine, sold under the brand name Pyribenzamine by Novartis, is a drug that is used as an antipruritic and first-generation antihistamine. Tripelennamine was first synthesized in 1946 by Carl Djerassi, working in the laboratory of Charles Huttrer at CIBA, shortly after Djerassi got his B.S. It was his first patent. One example is the line of Pyribenzamine Cough Syrups which contains codeine and with and without decongestants listed in the 1978 Physicians' Desk Reference; the codeine-tripelennamine synergy is well-known and does make such mixtures more useful for their intended purposes. Where and when it is/was in common use, tripelennamine is used much like other mildly-anticholinergic antihistamines for treating conditions of the upper respiratory tract arising from illnesses and hay fever. It has little to no anticholinergic activity. It can be used alone or in combination with other agents to have the desired effect. |
---|
Structure | CN(C)CCN(CC1=CC=CC=C1)C1=CC=CC=N1 InChI=1S/C16H21N3/c1-18(2)12-13-19(16-10-6-7-11-17-16)14-15-8-4-3-5-9-15/h3-11H,12-14H2,1-2H3 |
---|
Synonyms | Value | Source |
---|
PBZ-SR | HMDB | PBZ | HMDB | Azaron | HMDB | Tripelennamine citrate | HMDB | Tripelennamine maleate | HMDB | Tripelennamine maleate (1:1) | HMDB | Tripelennamine monohydrochloride | HMDB | Asid bonz brand OF tripelennamine hydrochloride | HMDB | Parnell brand OF tripelennamine hydrochloride | HMDB | Histantin | HMDB | Chefaro brand OF tripelennamine | HMDB | Pyribenzamine | HMDB | Tripelennamine citrate (1:1) | HMDB | Tripelennamine hydrochloride | HMDB | Vetibenzamin | HMDB |
|
---|
Chemical Formula | C16H21N3 |
---|
Average Molecular Weight | 255.358 |
---|
Monoisotopic Molecular Weight | 255.173547687 |
---|
IUPAC Name | N-benzyl-N-[2-(dimethylamino)ethyl]pyridin-2-amine |
---|
Traditional Name | tripelennamine |
---|
CAS Registry Number | 91-81-6 |
---|
SMILES | CN(C)CCN(CC1=CC=CC=C1)C1=CC=CC=N1 |
---|
InChI Identifier | InChI=1S/C16H21N3/c1-18(2)12-13-19(16-10-6-7-11-17-16)14-15-8-4-3-5-9-15/h3-11H,12-14H2,1-2H3 |
---|
InChI Key | UFLGIAIHIAPJJC-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as 2-benzylaminopyridines. These are aromatic compounds containing pyridine ring substituted at the 2-position by a benzylamine group. |
---|
Kingdom | Organic compounds |
---|
Super Class | Benzenoids |
---|
Class | Benzene and substituted derivatives |
---|
Sub Class | Benzylamines |
---|
Direct Parent | 2-benzylaminopyridines |
---|
Alternative Parents | |
---|
Substituents | - 2-benzylaminopyridine
- Dialkylarylamine
- Aminopyridine
- Pyridine
- Imidolactam
- Heteroaromatic compound
- Tertiary amine
- Tertiary aliphatic amine
- Azacycle
- Organoheterocyclic compound
- Hydrocarbon derivative
- Organopnictogen compound
- Organonitrogen compound
- Amine
- Organic nitrogen compound
- Aromatic heteromonocyclic compound
|
---|
Molecular Framework | Aromatic heteromonocyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 2.84 g/L | Not Available | LogP | 3.3 | Not Available |
|
---|
Experimental Chromatographic Properties | Experimental Collision Cross Sections |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatized |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental GC-MS | GC-MS Spectrum - Tripelennamine CI-B (Non-derivatized) | splash10-0a4i-0090000000-c34cc7c068c800fe56be | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Tripelennamine CI-B (Non-derivatized) | splash10-0a4i-0090000000-c34cc7c068c800fe56be | 2018-05-18 | HMDB team, MONA, MassBank | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Tripelennamine GC-MS (Non-derivatized) - 70eV, Positive | splash10-0a4l-9200000000-0d2486042b7353578cae | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Tripelennamine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Tripelennamine LC-ESI-QTOF , positive-QTOF | splash10-0bt9-0090000000-334f534255262b94521e | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Tripelennamine LC-ESI-QTOF , positive-QTOF | splash10-03di-0090000000-11e8826e02efb97b98c9 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Tripelennamine LC-ESI-QTOF , positive-QTOF | splash10-00kf-8930000000-1b7607b1d6869ef01c34 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Tripelennamine LC-ESI-QTOF , positive-QTOF | splash10-00kf-9500000000-e76eabb3bb757d44acfa | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Tripelennamine LC-ESI-QTOF , positive-QTOF | splash10-00kf-9400000000-e99107bbb2260bd80b26 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Tripelennamine , positive-QTOF | splash10-03di-0290000000-1cb8a1736406d2586266 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Tripelennamine 30V, Positive-QTOF | splash10-00kf-8930000000-1b7607b1d6869ef01c34 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Tripelennamine 40V, Positive-QTOF | splash10-00kf-9500000000-e76eabb3bb757d44acfa | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Tripelennamine 20V, Positive-QTOF | splash10-03di-0090000000-11e8826e02efb97b98c9 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Tripelennamine 10V, Positive-QTOF | splash10-0bt9-0090000000-334f534255262b94521e | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Tripelennamine 50V, Positive-QTOF | splash10-00kf-9400000000-e99107bbb2260bd80b26 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Tripelennamine 35V, Positive-QTOF | splash10-03xu-5980000000-cf619124133052cdb076 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Tripelennamine 50V, Positive-QTOF | splash10-00kf-9400000000-90b8e473a7785d05e3e6 | 2021-09-20 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tripelennamine 10V, Positive-QTOF | splash10-0a4i-4090000000-63473fef524306c78380 | 2016-08-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tripelennamine 20V, Positive-QTOF | splash10-022c-9240000000-25e1df027e0be085969b | 2016-08-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tripelennamine 40V, Positive-QTOF | splash10-0006-9100000000-33a105923d92b87de1ff | 2016-08-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tripelennamine 10V, Negative-QTOF | splash10-0udi-0490000000-0256a416c1400912ea41 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tripelennamine 20V, Negative-QTOF | splash10-0il0-1930000000-7b176551463e8116cd4a | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tripelennamine 40V, Negative-QTOF | splash10-05mo-8900000000-3d9f90a28663006a5cba | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tripelennamine 10V, Positive-QTOF | splash10-0a4i-0090000000-9e342109b20dc73fa830 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tripelennamine 20V, Positive-QTOF | splash10-052f-9070000000-6a0b0e49bbf73eb6092a | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tripelennamine 40V, Positive-QTOF | splash10-0a4l-9100000000-0481d3189f740271ebe5 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tripelennamine 10V, Negative-QTOF | splash10-0udi-0190000000-712806e1e23b489a9d3a | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tripelennamine 20V, Negative-QTOF | splash10-001i-2900000000-2f43d0aa493a7f363f01 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tripelennamine 40V, Negative-QTOF | splash10-0059-5900000000-d9e424d86a29fcaf4a75 | 2021-10-11 | Wishart Lab | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum |
|
---|